sotorasib
amgen
['codebreak 200', 'upgrade', 'rectal', 'urothelial', 'renal,(-adrenal)', 'colorectal']
#esmo22 day 4 highlights: significant results from codebreak 200 trial, upgraded data for renal cell carcinoma, cancer colorectal and urothelial cancer. 
Plan, consolidate data, and synthesize insights from life science conferences and social media with https://t.co/Fhm0QpaU5o, a product of @ZoomRx.